Combination gene therapy with PTEN and EGFR siRNA suppresses U251 malignant glioma cell growth in vitro and in vivo (Q39804055)

14 September 2017

Combination gene therapy with PTEN and EGFR siRNA suppresses U251 malignant glioma cell growth in vitro and in vivo (English)

1 reference

14 September 2017

0 references

1 reference

Lei Han

1

1 reference

14 September 2017

An-ling Zhang

2

1 reference

14 September 2017

Peng Xu

3

1 reference

14 September 2017

Xiao Yue

4

1 reference

14 September 2017

Yang Yang

5

1 reference

14 September 2017

Guang-xiu Wang

6

1 reference

14 September 2017

Zhi-fan Jia

7

1 reference

14 September 2017

Pei-yu Pu

8

1 reference

14 September 2017

Chun-sheng Kang

9

1 reference

14 September 2017

29 August 2009

1 reference

14 September 2017

1 reference

14 September 2017

27

1 reference

14 September 2017

3

1 reference

14 September 2017

843-852

1 reference

https://scigraph.springernature.com/pub.10.1007/s12032-009-9295-8

14 September 2017

0 references

cites work

Downregulation of PIK3CB by siRNA suppresses malignant glioma cell growth in vitro and in vivo

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS12032-009-9295-8

PTEN: from pathology to biology

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS12032-009-9295-8

Effects of cotransfection of antisense-EGFR and wild-type PTEN cDNA on human glioblastoma cells

21 January 2018

1 reference

12 December 2020

Development and maintenance of B and T lymphocytes requires antiapoptotic MCL-1.

1 reference

12 December 2020

Protein kinase B (PKB/Akt) activity is elevated in glioblastoma cells due to mutation of the tumor suppressor PTEN/MMAC.

1 reference

12 December 2020

Combination of all-trans retinoic acid and interferon-gamma suppressed PI3K/Akt survival pathway in glioblastoma T98G cells whereas NF-kappaB survival signaling in glioblastoma U87MG cells for induction of apoptosis.

1 reference

12 December 2020

The EGF receptor family as targets for cancer therapy

1 reference

12 December 2020

Inhibitory effect of antisense epidermal growth factor receptor RNA on the proliferation of rat C6 glioma cells in vitro and in vivo

1 reference

12 December 2020

Disappearance of the lymphoid system in Bcl-2 homozygous mutant chimeric mice

1 reference

12 December 2020

Amplification, enhanced expression and possible rearrangement of EGF receptor gene in primary human brain tumours of glial origin.

1 reference

12 December 2020

EGFR, HER-2/neu, cyclin D1, p21 and p53 in correlation to cell proliferation and steroid hormone receptor status in ductal carcinoma in situ of the breast

1 reference

12 December 2020

The molecular genetics of central nervous system tumors.

1 reference

12 December 2020

Understanding the role of tissue degrading enzymes and their inhibitors in development and disease

1 reference

12 December 2020

Enhanced skin carcinogenesis in cyclin D1-conditional transgenic mice: cyclin D1 alters keratinocyte response to calcium-induced terminal differentiation.

1 reference

12 December 2020

Suppression of EGFR expression by antisense or small interference RNA inhibits U251 glioma cell growth in vitro and in vivo

1 reference

12 December 2020

Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers

1 reference

12 December 2020

PTEN: The down side of PI 3-kinase signalling.

1 reference

12 December 2020

AKT plays a central role in tumorigenesis

1 reference

12 December 2020

The multiple roles of PTEN in tumor suppression

1 reference

12 December 2020

Malignant glioma: genetics and biology of a grave matter.

1 reference

12 December 2020

Molecular genetics of human glioma.

1 reference

12 December 2020

A tiger behind many doors: multiple genetic pathways to malignant glioma

1 reference

12 December 2020

PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer

1 reference

12 December 2020

Comparative genomic sequence analysis and isolation of human and mouse alternative EGFR transcripts encoding truncated receptor isoforms.

1 reference

12 December 2020

Tumor suppressor PTEN inhibits integrin- and growth factor-mediated mitogen-activated protein (MAP) kinase signaling pathways

1 reference

12 December 2020

Structure and function of matrix metalloproteinases and TIMPs

1 reference

12 December 2020

Molecular targeting for malignant gliomas (Review).

1 reference

12 December 2020

Massive cell death of immature hematopoietic cells and neurons in Bcl-x-deficient mice

1 reference

12 December 2020

In vitro and in vivo study of cell growth inhibition of simvastatin on chronic myelogenous leukemia cells

1 reference

12 December 2020

1 reference

12 December 2020

Regulation of matrix biology by matrix metalloproteinases

1 reference

12 December 2020

PTEN/MMAC1/TEP1 suppresses the tumorigenicity and induces G1 cell cycle arrest in human glioblastoma cells

1 reference

12 December 2020

Bcl-2-deficient mice demonstrate fulminant lymphoid apoptosis, polycystic kidneys, and hypopigmented hair

1 reference

12 December 2020

PTEN/MMAC1 mutations and EGFR amplification in glioblastomas.

1 reference

12 December 2020

Molecular genetics and molecular biology advances in brain tumors.

1 reference

12 December 2020

The Bcl-2 protein family: arbiters of cell survival

1 reference

12 December 2020

Immunohistochemical analysis of the patterns of p53 and PCNA expression in odontogenic cystic lesions.

1 reference

12 December 2020

10.1007/S12032-009-9295-8

Identifiers

DOI

1 reference

14 September 2017

1 reference